AIA Group Ltd Increases Stock Holdings in Cigna Group $CI

AIA Group Ltd raised its position in shares of Cigna Group (NYSE:CI) by 408.4% in the third quarter, HoldingsChannel reports. The firm owned 35,947 shares of the health services provider’s stock after buying an additional 28,877 shares during the quarter. AIA Group Ltd’s holdings in Cigna Group were worth $10,362,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the business. Norges Bank purchased a new stake in Cigna Group during the second quarter valued at approximately $1,110,426,000. Capital Research Global Investors boosted its stake in shares of Cigna Group by 140.2% during the 3rd quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after acquiring an additional 1,855,897 shares during the last quarter. Ameriprise Financial Inc. grew its position in shares of Cigna Group by 54.5% during the 3rd quarter. Ameriprise Financial Inc. now owns 2,136,311 shares of the health services provider’s stock valued at $615,781,000 after acquiring an additional 753,865 shares during the period. Arrowstreet Capital Limited Partnership grew its position in shares of Cigna Group by 24.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after acquiring an additional 492,045 shares during the period. Finally, Balyasny Asset Management L.P. increased its stake in shares of Cigna Group by 1,057.2% in the 2nd quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after purchasing an additional 369,775 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 0.5%

Shares of Cigna Group stock opened at $264.87 on Thursday. The company has a market capitalization of $69.80 billion, a P/E ratio of 11.94, a P/E/G ratio of 0.91 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The company has a fifty day moving average of $278.57 and a 200 day moving average of $282.09. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. The business had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period last year, the firm earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be given a dividend of $1.56 per share. This is an increase from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio (DPR) is 28.13%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on CI shares. Deutsche Bank Aktiengesellschaft raised their target price on Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a report on Tuesday, February 10th. TD Cowen upped their price target on Cigna Group from $333.00 to $338.00 and gave the stock a “buy” rating in a research report on Monday, February 9th. Zacks Research raised Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. Robert W. Baird lowered their price objective on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. Finally, Guggenheim reiterated a “buy” rating and set a $318.00 price objective on shares of Cigna Group in a research note on Monday, February 2nd. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $333.11.

Insider Activity at Cigna Group

In other news, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares in the company, valued at $1,638,119.70. This trade represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares in the company, valued at $9,432,044.77. This trade represents a 6.60% decrease in their position. The SEC filing for this sale provides additional information. 0.70% of the stock is currently owned by company insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.